author-photo

Sue Stephens

33

Papers

1944

Citations

Citation Trend

Filter By

Papers (24) Sort By

Journal Conference Others

P1-039 セルトリズマブペゴルの従来型TNF阻害薬と異なるプロファイルDifferent Profiles of Certolizumab Pegol from other TNF inhibitors

2012 Japanese Journal of Clinical Immunology
Show All
- Source
- Cite
- Save
Citations (0)
Effect of Sch 55700, a Humanized Monoclonal Antibody to Human Interleukin-5, on Eosinophilic Responses and Bronchial Hyperreactivity

2011 Drug Research
Show All
- Source
- Cite
- Save
Citations (101)
The Use of Surrogate Antibodies to Evaluate the Developmental and Reproductive Toxicity Potential of an Anti-TNFα PEGylated Fab′ Monoclonal Antibody

2011 Toxicological Sciences
Show All
- Source
- Cite
- Save
Citations (24)
Certolizumab pegol: a PEGylated anti-tumour necrosis factor alpha biological agent

2009
Show All
- Source
- Cite
- Save
Citations (8)
Neutralizing antibodies to certolizumab pegol do not appear to affect efficacy and safety in patients with Crohnʼs disease: P-055.

2008 Inflammatory Bowel Diseases
Show All
- Source
- Cite
- Save
Citations (0)
An Engineered Human Antibody for Chronic Therapy: CDP571

2008
- Mark Sopwith
- Sue Stephens
Show All
- Source
- Cite
- Save
Citations (1)
P152 Lack of Placental Transfer and Accumulation in Milk of an Anti-TNF Pegylated Fab'Fragment in Rats

2007 Journal of Crohn's and Colitis Supplements
Show All
- Source
- Cite
- Save
Citations (11)
Lack of placental transfer and accumulation in milk of an anti-TNF PEGylated Fabʼ fragment in rats: P-0030

2007 Inflammatory Bowel Diseases
Show All
- Source
- Cite
- Save
Citations (1)
Mechanism of action of certolizumab pegol (CDP870): In vitro comparison with other anti-tumor necrosis factor α agents

2007 Inflammatory Bowel Diseases
Show All
- Source
- Cite
- Save
Citations (402)
Efficacy and Safety of Certolizumab Pegol Do Not Appear To Be Affected by Neutralizing Antibodies in Patients with Crohnʼs Disease: 971

2007 The American Journal of Gastroenterology
Show All
- Source
- Cite
- Save
Citations (0)